- Home
- NVO vs SHEL Comparison
NVO vs SHEL Comparison
Compare NVO & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- SHEL
- Stock Information
- Founded
- NVO 1923
- SHEL 1907
- Country
- NVO Denmark
- SHEL United Kingdom
- Employees
- NVO N/A
- SHEL N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- SHEL Oil & Gas Production
- Sector
- NVO Health Care
- SHEL Energy
- Exchange
- NVO Nasdaq
- SHEL Nasdaq
- Market Cap
- NVO 243.4B
- SHEL 215.9B
- IPO Year
- NVO N/A
- SHEL N/A
- Fundamental
- Price
- NVO $48.84
- SHEL $73.54
- Analyst Decision
- NVO Buy
- SHEL Buy
- Analyst Count
- NVO 9
- SHEL 9
- Target Price
- NVO $54.33
- SHEL $80.76
- AVG Volume (30 Days)
- NVO 24.1M
- SHEL 4.4M
- Earning Date
- NVO 11-05-2025
- SHEL 10-30-2025
- Dividend Yield
- NVO 2.53%
- SHEL 3.90%
- EPS Growth
- NVO 10.06
- SHEL N/A
- EPS
- NVO 3.67
- SHEL 2.42
- Revenue
- NVO $49,580,393,058.00
- SHEL $269,075,000,000.00
- Revenue This Year
- NVO $9.21
- SHEL N/A
- Revenue Next Year
- NVO $5.64
- SHEL N/A
- P/E Ratio
- NVO $13.29
- SHEL $30.35
- Revenue Growth
- NVO 16.64
- SHEL N/A
- 52 Week Low
- NVO $43.08
- SHEL $58.55
- 52 Week High
- NVO $112.52
- SHEL $77.47
- Technical
- Relative Strength Index (RSI)
- NVO 47.14
- SHEL 44.75
- Support Level
- NVO $43.08
- SHEL $72.46
- Resistance Level
- NVO $49.53
- SHEL $74.61
- Average True Range (ATR)
- NVO 1.37
- SHEL 0.94
- MACD
- NVO 0.24
- SHEL -0.37
- Stochastic Oscillator
- NVO 77.01
- SHEL 20.76
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.